{"product_id":"orpea-group-five-forces-analysis","title":"Orpea Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eA Must-Have Tool for Decision-Makers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cporpea faces moderate buyer power high regulatory scrutiny and stiff rivalry amid consolidation reputation risks scale specialized care services offer defensive moats this snapshot highlights key competitive tensions but omits detailed metrics force-by-force ratings.\u003e\u003cp\u003eUnlock the full Porter's Five Forces Analysis to explore Orpea’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/porpea\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScarcity of specialized medical and nursing staff\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrimary suppliers for Orpea are skilled nurses and caregivers; their bargaining power is high due to chronic global shortages in geriatric care. As of late 2025, nurse vacancy rates in Western Europe averaged ~12–14%, forcing Orpea to raise wages by roughly 8–11% and invest in benefits to meet mandated staffing ratios. Labor costs now account for about 55–60% of operating expenses, constraining margin compression. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReal estate developers and landlords\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOrpea depends on developers and REITs for sites; by 2024 around 40% of its estate was leased, raising supplier leverage during renewals.\u003c\/p\u003e\n\u003cp\u003eThe asset-light shift lowers capital burden but healthcare-specific layouts limit relocations, so landlords can demand higher rents or stricter terms.\u003c\/p\u003e\n\u003cp\u003eRising construction costs—EU average +12% in 2023—and higher borrowing rates (ECB policy rate 3.75% end-2024) strengthen owners’ bargaining power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical and medical equipment providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers of specialized devices, diagnostics, and drugs hold moderate power over Orpea because their products are essential; in 2024 Orpea bought €1.2bn of medical supplies, letting scale secure volume discounts but not full price control.\u003c\/p\u003e\n\u003cp\u003eMany life‑saving drugs and advanced rehab tools have few substitutes, so switching is hard; regulatory constraints (EU MDR, national drug approvals) further limit moves to lower‑cost, unverified suppliers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy and utility providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEnergy needs for Orpea’s care homes are high—heating, cooling, and medical gear can account for 12–18% of operating costs; in 2024 European industrial electricity prices averaged ~€0.18\/kWh, up ~35% vs 2020, and volatility persisted into 2025.\u003c\/p\u003e\n\u003cp\u003eOrpea faces weak bargaining power vs local utility monopolies, creating fixed-cost pressure that is hard to cut without capex: on-site solar+storage payback often exceeds 8–12 years for large campuses.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eEnergy share: 12–18% of ops costs\u003c\/li\u003e\n\u003cli\u003eEU avg price 2024: ~€0.18\/kWh (+35% vs 2020)\u003c\/li\u003e\n\u003cli\u003eVolatility persisted into 2025\u003c\/li\u003e\n\u003cli\u003eOn-site green capex payback: 8–12 years\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFood service and facility management vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpoutsourced catering laundry and specialist cleaning keep orpea premium care standard but strict hygiene certifications en proven track records cut the supplier pool raising switching costs dependency risks a survey showed of european homes cite vendor reliability as critical. must trade lower contract versus reputational damage from service failures.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh dependency: few certified vendors raise switching costs\u003c\/li\u003e\n\u003cli\u003eRisk metric: 62% cite vendor reliability (2024)\u003c\/li\u003e\n\u003cli\u003eCost trade-off: lower price vs reputational risk\u003c\/li\u003e\n\u003cli\u003eMitigation: multi-vendor contracts, SLAs, contingency stocks\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/poutsourced\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier squeeze: rising wages, leased estates and €1.2bn supply costs bite margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers exert above‑average power: labor shortages (nurse vacancy ~12–14% in W. Europe) pushed Orpea to raise wages ~8–11%, making labor 55–60% of costs; landlords hold leverage with ~40% leased estate; medical suppliers are moderately powerful (Orpea bought €1.2bn supplies in 2024); utilities and outsourced services add fixed-cost and switching risks.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024–25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNurse vacancy W. Europe\u003c\/td\u003e\n\u003ctd\u003e12–14%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWage uplift\u003c\/td\u003e\n\u003ctd\u003e+8–11%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLabor share\u003c\/td\u003e\n\u003ctd\u003e55–60% ops\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeased estate\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical supplies spend\u003c\/td\u003e\n\u003ctd\u003e€1.2bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy price EU avg\u003c\/td\u003e\n\u003ctd\u003e~€0.18\/kWh (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis for Orpea that uncovers competitive drivers, supplier and buyer power, entry barriers, substitute threats, and disruptive risks—designed for easy incorporation into investor reports, strategy decks, or academic work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCompact Porter's Five Forces for Orpea—clear single-sheet view to speed strategic decisions and spot regulatory, supplier, and reputational pressures at a glance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState and social security reimbursement bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn countries like France and Germany, national health insurers and social security bodies set reimbursement rates and occupancy subsidies, giving them immense bargaining power over Orpea; in France public payers cover ~60–70% of long-term care funding and reimbursed tariffs rose \u0026lt;2% annually 2019–2024 while labor costs climbed ~20% (2019–2024), squeezing margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndividual residents and their families\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWealthier private-pay residents exert strong bargaining power: in France and Germany roughly 20–30% of clients are private-pay, and premium providers compete on service and pricing, pushing Orpea to match higher standards and margins.\u003c\/p\u003e\n\u003cp\u003eAfter the 2020–2022 scandals, 68% of families say transparency is a deal-breaker, raising demands for accountability and contract clarity.\u003c\/p\u003e\n\u003cp\u003eOnline reviews and national quality ratings (e.g., France’s 2024 HAS indicators) let customers compare care; facilities losing one-star equivalents can see occupancy drops of 5–10% within 12 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInsurance companies and private health funds\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrivate insurers and health funds bargain hard, using member pools to secure bulk rates—France’s complementary insurers covered ~77% of rehab stays in 2023, pushing average price discounts of 8–15% versus list rates.\u003c\/p\u003e\n\u003cp\u003eAs Orpea grew post-acute revenue to ~€420m in 2024, dependence on institutional payers rose, concentrating pricing risk.\u003c\/p\u003e\n\u003cp\u003ePayers enforce clinical pathways and audits; failing audits can drop Orpea from preferred lists and cut occupancy by double-digit points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow switching costs for prospective residents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eWhile relocating a resident is emotionally and physically hard, the pre-admission choice is fiercely competitive: 74% of French families surveyed in 2024 compared three or more facilities by location, price, and services before signing, per INSEE-linked sector data.\u003c\/p\u003e\n\u003cp\u003eThis transparency and price visibility mean Orpea must sustain high clinical, staffing, and amenity standards to win new admissions in a market with ~12% annual turnover of open beds.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: 3x options reviewed × 12% bed churn raises marketing and quality costs by an estimated 150–220 basis points of revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh pre-admission comparison: 74% compared ≥3 facilities\u003c\/li\u003e\n\u003cli\u003eMarket churn pressure: ~12% annual open-bed turnover\u003c\/li\u003e\n\u003cli\u003eCost impact: quality\/marketing +150–220 bps of revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of advocacy groups and patient unions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePatient rights orgs and elderly advocacy groups shape legislation and public opinion, indirectly cutting Orpea’s pricing autonomy after 2022 scandals that led to a 15% French revenue hit in 2023 for reputation remediation.\u003c\/p\u003e\n\u003cp\u003eThe groups lobby for tighter quality and pricing rules; EU inquiries and fines since 2022 raise compliance costs and limit margin expansion.\u003c\/p\u003e\n\u003cp\u003eTheir mobilization power—media campaigns and class actions—elevates switching and regulatory risk for Orpea, pressuring service fees and investor sentiment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAdvocacy-driven regulation reduces pricing flexibility\u003c\/li\u003e\n\u003cli\u003e2022–2023 scandals cost ~15% French revenue\u003c\/li\u003e\n\u003cli\u003eMedia\/class actions raise compliance and legal costs\u003c\/li\u003e\n\u003cli\u003ePublic mobilization increases switching and funding risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInsurers squeeze tariffs; ratings shift occupancy ±10%—€420m institutional risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePayers (public insurers cover ~60–70% in France) and private insurers force tariffs and bulk discounts (8–15%), while private-pay clients (20–30%) demand premium services; post-2020 scandals transparency needs (68% families) and quality ratings (HAS 2024) drive 5–10% occupancy swings, raising marketing\/quality costs ~150–220 bps and concentrating pricing risk as institutional revenue reached ~€420m (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic funding share (FR)\u003c\/td\u003e\n\u003ctd\u003e60–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivate-pay share\u003c\/td\u003e\n\u003ctd\u003e20–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy drop after rating loss\u003c\/td\u003e\n\u003ctd\u003e5–10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarketing\/quality cost\u003c\/td\u003e\n\u003ctd\u003e+150–220 bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInstitutional revenue\u003c\/td\u003e\n\u003ctd\u003e€420m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eOrpea Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Orpea Porter's Five Forces analysis you'll receive immediately after purchase—fully formatted, professionally written, and ready to download with no placeholders or samples.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747249860985,"sku":"orpea-group-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/orpea-group-five-forces-analysis.png?v=1772196574","url":"https:\/\/matrixbcg.com\/products\/orpea-group-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}